144 related articles for article (PubMed ID: 16138425)
1. The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia.
Siegman-Igra Y; Reich P; Orni-Wasserlauf R; Schwartz D; Giladi M
Scand J Infect Dis; 2005; 37(8):572-578. PubMed ID: 16138425
[TBL] [Abstract][Full Text] [Related]
2. Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia.
Britt NS; Patel N; Shireman TI; El Atrouni WI; Horvat RT; Steed ME
J Antimicrob Chemother; 2017 Feb; 72(2):535-542. PubMed ID: 27999028
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
[TBL] [Abstract][Full Text] [Related]
4. Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort study.
Forsblom E; Ruotsalainen E; Järvinen A
PLoS One; 2015; 10(4):e0122824. PubMed ID: 25874546
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of Staphylococcus aureus bacteraemia.
Mitchell DH; Howden BP
Intern Med J; 2005 Dec; 35 Suppl 2():S17-24. PubMed ID: 16271058
[TBL] [Abstract][Full Text] [Related]
6. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
Khatib R; Johnson LB; Sharma M; Fakih MG; Ganga R; Riederer K
Scand J Infect Dis; 2009; 41(1):4-9. PubMed ID: 18821135
[TBL] [Abstract][Full Text] [Related]
7. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
Cervera C; Castañeda X; de la Maria CG; del Rio A; Moreno A; Soy D; Pericas JM; Falces C; Armero Y; Almela M; Ninot S; Pare JC; Mestres CA; Gatell JM; Marco F; Miro JM;
Clin Infect Dis; 2014 Jun; 58(12):1668-75. PubMed ID: 24647021
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia.
Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Warren SJ; Gao W; Johnson PD; Howden BP
Clin Microbiol Infect; 2013 Dec; 19(12):1163-8. PubMed ID: 23441652
[TBL] [Abstract][Full Text] [Related]
9. [Cloxacillin-susceptible Staphylococcus aureus with high MIC to glycopeptides. Ever we use cloxacillin?].
Morales-Cartagena A; Lalueza A; San Juan R; Aguado JM
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():25-9. PubMed ID: 26365730
[TBL] [Abstract][Full Text] [Related]
10. Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.
Shorr AF; Kunkel MJ; Kollef M
J Antimicrob Chemother; 2005 Nov; 56(5):923-9. PubMed ID: 16195255
[TBL] [Abstract][Full Text] [Related]
11. Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.
Goldberg E; Paul M; Talker O; Samra Z; Raskin M; Hazzan R; Leibovici L; Bishara J
J Antimicrob Chemother; 2010 Aug; 65(8):1779-83. PubMed ID: 20507860
[TBL] [Abstract][Full Text] [Related]
12. Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia.
Holmes NE; Robinson JO; van Hal SJ; Munckhof WJ; Athan E; Korman TM; Cheng AC; Turnidge JD; Johnson PDR; Howden BP;
BMC Infect Dis; 2018 Mar; 18(1):107. PubMed ID: 29506483
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study.
Bai AD; Showler A; Burry L; Steinberg M; Ricciuto DR; Fernandes T; Chiu A; Raybardhan S; Science M; Fernando E; Tomlinson G; Bell CM; Morris AM
J Antimicrob Chemother; 2015 May; 70(5):1539-46. PubMed ID: 25614044
[TBL] [Abstract][Full Text] [Related]
14. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC
J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337
[TBL] [Abstract][Full Text] [Related]
15. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.
Kaech C; Elzi L; Sendi P; Frei R; Laifer G; Bassetti S; Fluckiger U
Clin Microbiol Infect; 2006 Apr; 12(4):345-52. PubMed ID: 16524411
[TBL] [Abstract][Full Text] [Related]
16. Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.
Kalil AC; Van Schooneveld TC; Fey PD; Rupp ME
JAMA; 2014 Oct; 312(15):1552-64. PubMed ID: 25321910
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.
Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Gao W; Christiansen KJ; Coombs GW; Johnson PD; Howden BP
J Infect Dis; 2011 Aug; 204(3):340-7. PubMed ID: 21742831
[TBL] [Abstract][Full Text] [Related]
18. Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia.
Lalani T; Boucher HW; Cosgrove SE; Fowler VG; Kanafani ZA; Vigliani GA; Campion M; Abrutyn E; Levine DP; Price CS; Rehm SJ; Corey GR; Karchmer AW;
J Antimicrob Chemother; 2008 Jan; 61(1):177-82. PubMed ID: 17999973
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic changes of methicillin-resistant Staphylococcus aureus during vancomycin therapy for persistent bacteraemia and related clinical outcome.
Kim T; Kim ES; Park SY; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Chong YP; Kim YS
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1473-1481. PubMed ID: 28337607
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.
Cantoni L; Wenger A; Glauser MP; Bille J
J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846
[No Abstract] [Full Text] [Related]
[Next] [New Search]
